Search research articles
Contact Us
Filters
Showing results (191-200 of 539) with videos related to
Page
of 54
Sort By:
Respiratory Medicine
|
September 1, 1995
Assessing equivalence of inhaled drugs
R W Fuller, C Hallett, R Dahl
Research Communications in Chemical Pathology and Pharmacology
|
March 1, 1983
Evidence for inhibition of monoamine oxidase in vivo in rat brain by 7,8-dichloro-1,2,3,4-tetrahydroisoquinoline
R W Fuller, S K Hemrick-Luecke
Research Communications in Chemical Pathology and Pharmacology
|
May 1, 1981
Elevation of epinephrine concentration in rat brain by LY51641, a selective inhibitor of type A monoamine oxidase
R W Fuller, S K Hemrick-Luecke
Research Communications in Chemical Pathology and Pharmacology
|
December 1, 1980
Comparison of some conformationally rigid benzylamine analogs as substrates for rabbit lung N-methyltransferase
R W Fuller, S K Hemrick-Luecke
European Journal of Pharmacology
|
September 12, 1996
Involvement of 5-HT2A receptors in the elevation of rat serum corticosterone concentrations by quipazine and MK-212
S K Hemrick-Luecke, R W Fuller
Comparative Biochemistry and Physiology. C, Comparative Pharmacology and Toxicology
|
January 1, 1983
Species differences in epinephrine concentration and norepinephrine N-methyltransferase activity in hypothalamus and brain stem
R W Fuller, S K Hemrick-Luecke
Life Sciences
|
September 23, 1985
Influence of selective, reversible inhibitors of monoamine oxidase on the prolonged depletion of striatal dopamine by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice
R W Fuller, S K Hemrick-Luecke
Research Communications in Chemical Pathology and Pharmacology
|
April 1, 1985
Effects of amfonelic acid, alpha-methyltyrosine, Ro 4-1284 and haloperidol pretreatment on the depletion of striatal dopamine by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice
R W Fuller, S K Hemrick-Luecke
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
January 1, 1985
Mechanisms of MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) neurotoxicity to striatal dopamine neurons in mice
R W Fuller, S K Hemrick-Luecke
Toxicology Letters
|
December 1, 1990
Tissue concentrations of MPTP and MPP+ after administration of lethal and sublethal doses of MPTP to mice
R W Fuller, S K Hemrick-Luecke
Page
of 54
Search research articles
Search
Showing results (191-200 of 539) with videos related to
Sort By:
Page
of 54
Respiratory Medicine
|
September 1, 1995
Assessing equivalence of inhaled drugs
R W Fuller, C Hallett, R Dahl
Research Communications in Chemical Pathology and Pharmacology
|
March 1, 1983
Evidence for inhibition of monoamine oxidase in vivo in rat brain by 7,8-dichloro-1,2,3,4-tetrahydroisoquinoline
R W Fuller, S K Hemrick-Luecke
Research Communications in Chemical Pathology and Pharmacology
|
May 1, 1981
Elevation of epinephrine concentration in rat brain by LY51641, a selective inhibitor of type A monoamine oxidase
R W Fuller, S K Hemrick-Luecke
Research Communications in Chemical Pathology and Pharmacology
|
December 1, 1980
Comparison of some conformationally rigid benzylamine analogs as substrates for rabbit lung N-methyltransferase
R W Fuller, S K Hemrick-Luecke
European Journal of Pharmacology
|
September 12, 1996
Involvement of 5-HT2A receptors in the elevation of rat serum corticosterone concentrations by quipazine and MK-212
S K Hemrick-Luecke, R W Fuller
Comparative Biochemistry and Physiology. C, Comparative Pharmacology and Toxicology
|
January 1, 1983
Species differences in epinephrine concentration and norepinephrine N-methyltransferase activity in hypothalamus and brain stem
R W Fuller, S K Hemrick-Luecke
Life Sciences
|
September 23, 1985
Influence of selective, reversible inhibitors of monoamine oxidase on the prolonged depletion of striatal dopamine by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice
R W Fuller, S K Hemrick-Luecke
Research Communications in Chemical Pathology and Pharmacology
|
April 1, 1985
Effects of amfonelic acid, alpha-methyltyrosine, Ro 4-1284 and haloperidol pretreatment on the depletion of striatal dopamine by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice
R W Fuller, S K Hemrick-Luecke
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
January 1, 1985
Mechanisms of MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) neurotoxicity to striatal dopamine neurons in mice
R W Fuller, S K Hemrick-Luecke
Toxicology Letters
|
December 1, 1990
Tissue concentrations of MPTP and MPP+ after administration of lethal and sublethal doses of MPTP to mice
R W Fuller, S K Hemrick-Luecke
Page
of 54